Spliceosome Mutations Involving SRSF2, SF3B1 and U2AF35 in World Health Organization Defined Chronic Myelomonocytic Leukemia; Prevalence, Clinical Correlates and Prognosis

被引:1
|
作者
Patnaik, Mrinal M. [1 ]
Lasho, Terra L. [1 ]
Finke, Christy [1 ]
Hanson, Curtis A.
Hodnefield, Janice M. [2 ]
Knudson, Ryan A. [3 ]
Ketterling, Rhett P. [3 ]
Pardanani, Animesh [1 ]
Tefferi, Ayalew [1 ]
机构
[1] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Div Hematopathol, Rochester, MN USA
[3] Mayo Clin, Dept Lab Med, Cytogenet Div, Rochester, MN USA
关键词
D O I
10.1182/blood.V120.21.1711.1711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1711
引用
收藏
页数:2
相关论文
共 27 条
  • [1] Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance
    Patnaik, Mrinal M.
    Lasho, Terra L.
    Finke, Christy M.
    Hanson, Curtis A.
    Hodnefield, Janice M.
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Pardanani, Animesh
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (03) : 201 - 206
  • [2] Phenotypic and Prognostic Correlates of Spliceosome Mutations (SRSF2, SF3B1, U2AF35) in Chronic Myelomonocytic Leukemia with ≥ 1% Ring Sideroblasts.
    Patnaik, Mrinal M.
    Lasho, Terra L.
    Hanson, Curtis A.
    Hodnefield, Janice M.
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Pardanani, Animesh
    Tefferi, Ayalew
    BLOOD, 2012, 120 (21)
  • [3] Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia
    Stefanos A. Bamopoulos
    Aarif M. N. Batcha
    Vindi Jurinovic
    Maja Rothenberg-Thurley
    Hanna Janke
    Bianka Ksienzyk
    Julia Philippou-Massier
    Alexander Graf
    Stefan Krebs
    Helmut Blum
    Stephanie Schneider
    Nikola Konstandin
    Maria Cristina Sauerland
    Dennis Görlich
    Wolfgang E. Berdel
    Bernhard J. Woermann
    Stefan K. Bohlander
    Stefan Canzar
    Ulrich Mansmann
    Wolfgang Hiddemann
    Jan Braess
    Karsten Spiekermann
    Klaus H. Metzeler
    Tobias Herold
    Leukemia, 2020, 34 : 2621 - 2634
  • [4] Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia
    Bamopoulos, Stefanos A.
    Batcha, Aarif M. N.
    Jurinovic, Vindi
    Rothenberg-Thurley, Maja
    Janke, Hanna
    Ksienzyk, Bianka
    Philippou-Massier, Julia
    Graf, Alexander
    Krebs, Stefan
    Blum, Helmut
    Schneider, Stephanie
    Konstandin, Nikola
    Sauerland, Maria Cristina
    Goerlich, Dennis
    Berdel, Wolfgang E.
    Woermann, Bernhard J.
    Bohlander, Stefan K.
    Canzar, Stefan
    Mansmann, Ulrich
    Hiddemann, Wolfgang
    Braess, Jan
    Spiekermann, Karsten
    Metzeler, Klaus H.
    Herold, Tobias
    LEUKEMIA, 2020, 34 (10) : 2621 - 2634
  • [5] No Mutations of SF3B1, U2AF1, and SRSF2 spliceosomal Gene but Polymorphisms Associated with the Worse Prognosis in Multiple Myeloma
    Kang, Min-Gu
    Kim, Hye-Ran
    Lee, Jun Hyung
    Ganapathy, Thashma Pemmanda
    Yang, Seung-Hyeon
    Hoque, Moinul
    Park, Ra-Young
    Kee, Seung Jung
    Kim, Soo Hyun
    Shin, Jong-Hee
    Suh, Soon-Pal
    Shin, Myung-Geun
    BLOOD, 2015, 126 (23)
  • [6] SPLICEOSOME COMPONENT MUTATIONS AND CYTOGENETIC CORRELATES IN WORLD HEALTH ORGANIZATION (WHO)-DEFINED CHRONIC MYELOMONOCYTIC LEUKEMIA
    Parikh, S.
    Patnaik, M.
    Lasho, T.
    Finke, C.
    Hanson, C.
    Hodnefield, J.
    Knudson, R.
    Ketterling, R.
    Pardanani, A.
    Tefferi, A.
    HAEMATOLOGICA, 2013, 98 : 116 - 116
  • [7] ALTERATION OF SF3B1, U2AF1, AND SRSF2 SPLICEOSOMAL GENE AND THEIR CLINICAL IMPLICATION IN MULTIPLE MYELOMA
    Kang, Min-Gu
    Lee, Jun-Hyung
    Kim, Hye-Ran
    Kim, Hwan-Young
    Park, Ra-Young
    Choi, Hyun-Jung
    Kee, Seung-Jung
    Kim, Soo-Hyun
    Shin, Jong-Hee
    Suh, Soon-Pal
    Shin, Myung-Geun
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 51 - 52
  • [8] Clinical Significance Of SF3B1, U2AF1 and SRSF2 Spliceosomal Gene Mutations For The Treatment Of Hypomethylating Agents In Myelodysplastic Syndrome
    Ahn, Jae-Sook
    Kim, Hye-Ran
    Kim, Hyeoung-Joon
    Kim, Yeo-Kyeoung
    Jung, Sung-Hoon
    Yang, Deok-Hwan
    Lee, Je-Jung
    Nguyen Thi Dai Trang
    Choi, Hyun-Woo
    Kang, Min-Gu
    Kim, Hwan-Young
    Shin, Jong-Hee
    Suh, Soon-Pal
    Ryang, Dong-Wook
    Shin, Myung-Geun
    BLOOD, 2013, 122 (21)
  • [9] Mutational Analysis of Splicing Factor Genes SF3B1, U2AF1, ZRSR2, SRSF2, and U2AF2 in Chinese Patients With Acute Myeloid Leukemia
    Xing, Fei
    Sun, Qi
    Lin, Ya N.
    Qin, Li
    Jia, Yu J.
    Ru, Kun
    Zhang, Dong L.
    LABORATORY INVESTIGATION, 2018, 98 : 566 - 566
  • [10] Mutational Analysis of Splicing Factor Genes SF3B1, U2AF1, ZRSR2, SRSF2, and U2AF2 in Chinese Patients With Acute Myeloid Leukemia
    Xing, Fei
    Sun, Qi
    Lin, Ya N.
    Qin, Li
    Jia, Yu J.
    Ru, Kun
    Zhang, Dong L.
    MODERN PATHOLOGY, 2018, 31 : 566 - 566